Correlation Between CytomX Therapeutics and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Apellis Pharmaceuticals, you can compare the effects of market volatilities on CytomX Therapeutics and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Apellis Pharmaceuticals.
Diversification Opportunities for CytomX Therapeutics and Apellis Pharmaceuticals
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CytomX and Apellis is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Apellis Pharmaceuticals
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 2.39 times more return on investment than Apellis Pharmaceuticals. However, CytomX Therapeutics is 2.39 times more volatile than Apellis Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 288.00 in CytomX Therapeutics on August 31, 2024 and sell it today you would lose (182.00) from holding CytomX Therapeutics or give up 63.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.79% |
| Values | Daily Returns |
CytomX Therapeutics vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| CytomX Therapeutics |
| Apellis Pharmaceuticals |
CytomX Therapeutics and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Apellis Pharmaceuticals
The main advantage of trading using opposite CytomX Therapeutics and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
| Apellis Pharmaceuticals vs. Cue Biopharma | Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. Inhibrx | Apellis Pharmaceuticals vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |